Tradestie Institutional Equity Comparison Engine

TERN vs AURA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TERN Overall Edge

TERN Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Terns Pharmaceuticals, Inc. Common Stock (TERN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, TERN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus AURA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, TERN sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against AURA sits in CONSOLIDATION (22nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
TERN N/M vs AURA N/M Fwd P/E
Growth & Margin Winner TERN
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner TERN
1Y +1387.4% vs +30.4% ยท 52W Pos 100% vs 52%
Options & Structure Winner TERN
UNCLASSIFIED (<1st %ile IV) vs CONSOLIDATION (22nd %ile IV)
TERN NASDAQ
Terns Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$52.95
+0.04% 1D
Market Cap $6.1B
1M Return +0.44%
1Y Return +1387.36%
Forward P/E N/M
Unified AI Score
51.9 / 100 HOLD
Tech 40.0 Fund 42.0 Flow 60.0 Mom 21.1
AURA NASDAQ
Aura Biosciences, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$7.21
+1.41% 1D
Market Cap $728.6M
1M Return +18.2%
1Y Return +30.38%
Forward P/E N/M
Unified AI Score
28.8 / 100 SELL
Tech 50.0 Fund 39.0 Flow 71.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TERN +1387.36% AURA +30.38% Spread: +104.44 pp (TERN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
TERN TTM Op. Margin: 0.0% AURA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TERN vs AURA. Trailing 12-month operating profitability (TERN 0.0% vs AURA 0.0%) and valuation multiples (TERN N/M vs AURA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TERN (5) vs AURA (0)
Institutional Metric TERN AURA Criterion Row Winner
Market Capitalization Scale $6.1B $728.6M Larger Scale TERN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -14.2% -61.7% Higher ROE TERN
52-Week Range Position Momentum 100% ($3โ€“$53) 52% ($5โ€“$10) Stronger Trend TERN
Beta / 30D Volatility Risk Regime 0.07ฮฒ ยท 2% Vol 0.92ฮฒ ยท 75% Vol Lower Realized Risk TERN
Unified Institutional Score Composite Signal 51.9 / 100 (HOLD) 28.8 / 100 (SELL) Higher Composite TERN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TERN vs AURA Buy Guide
TERN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live TERN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AURA CONSOLIDATION
135d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 22nd %ile
IV Regime Compressed (<25th %ile)
Live AURA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TERN nor AURA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.